Ginger Compound and Drug Combo Shows New Hope for MS Recovery and Reducing Neuroinflammation
Nikhil Prasad Fact checked by:Thailand Medical News Team Jun 29, 2026 1 hour, 16 minutes ago
Medical News: A new experimental treatment combining a natural compound from ginger with an anti-inflammatory drug is showing promising results in improving symptoms linked to multiple sclerosis (MS), according to a recent study. Researchers say the dual approach may offer a powerful new way to reduce brain inflammation and restore lost function.
A new combination of ginger extract and a brain drug shows powerful effects in reversing MS-like damage in early
research
Understanding Multiple Sclerosis
Multiple sclerosis is a long-term condition where the immune system mistakenly attacks the protective covering of nerve fibers in the brain and spinal cord. This damage disrupts communication between the brain and the rest of the body, leading to symptoms such as muscle weakness, poor coordination, and memory problems.
Although treatments exist to slow disease progression, there is still no cure, and restoring damaged nerve insulation—known as myelin—remains a major challenge.
Who Conducted the Study
The research was carried out by scientists from several institutions, including:
-Department of Biochemistry, Faculty of Sciences, King Abdulaziz University, Saudi Arabia
-Neuroscience and Geroscience Research Unit, King Fahd Medical Research Center, Saudi Arabia
-Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University
-Department of Physiology, Faculty of Medicine, King Abdulaziz University
Princess Dr. Najla Bint Saud Al-Saud Center for Excellence Research in Biotechnology
-Stem Cell Unit, King Fahd Medical Research Center
-Department of Health Information Technology, King Abdulaziz University
-Department of Chemistry, Al-Baha University, Saudi Arabia
What Makes This Combination Special
The researchers tested a combination of:
-6-shogaol, a natural compound found in ginger known for its anti-inflammatory and antioxidant effects
-Ibudilast, a drug already studied for its ability to reduce brain inflammation
Individually, both have shown benefits. But this study explored what happens when they are used together.
How the Study Was Done
Scientists used a mouse model that mimics MS-like brain damage. The mice were first given a substance that causes loss of myelin, followed by a recovery phase where treatments were introduced.
The animals were divided into groups receiving either no treatment, one of the compounds alone, or the combination.
Researchers then measured:
-Movement and coordination
-Muscle strength
-Memory performance
-Levels of inflammation-related genes in the brain
Strong Improvements in Movement and Memory
The results were striking. Mice receiving the combined treatment showed the greatest improvement in physical abilit
ies. They moved faster, had better balance, and stronger muscles compared to untreated mice.
Memory also improved significantly. In tests where mice had to recognize new objects, those given the combination therapy performed much better, indicating recovery of cognitive function.
Reduced Brain Inflammation
At the molecular level, the combination therapy significantly reduced harmful inflammation signals in the brain. Key inflammatory markers such as TNF-alpha and NF-kB were lowered.
At the same time, beneficial protective pathways were activated. The treatment increased levels of Nrf2, a protein that helps cells fight oxidative stress, and IL-4, which supports healing and reduces inflammation.
This
Medical News report highlights how targeting both inflammation and oxidative stress together may be more effective than treating either alone.
Why the Combination Works Better
The study suggests that each component plays a different role:
-6-shogaol boosts the body’s natural defense systems and reduces oxidative damage
-Ibudilast suppresses harmful immune activity in the brain
When combined, they create a broader protective effect, improving both brain function and physical performance.
Key Takeaways and Conclusion
The findings point toward a promising new strategy for treating multiple sclerosis by combining natural compounds with existing drugs. The dual approach appears to address several underlying causes of the disease at once, including inflammation, oxidative stress, and nerve damage.
Importantly, the study showed that the combination worked better than either treatment alone, especially in restoring memory and muscle strength. While the results are encouraging, more research is needed to confirm whether the same benefits will be seen in humans.
Overall, this research opens the door to more effective multi-target therapies that could one day improve the quality of life for millions living with MS. By focusing not just on slowing the disease but also on repairing damage, scientists may be moving closer to a meaningful breakthrough.
The study findings were published in the peer reviewed journal: Pharmaceuticals.
https://www.mdpi.com/1424-8247/19/7/1004
For the latest on treating neuroinflammation, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/neuroinflammation-breakthroughs-open-new-frontiers-in-brain-disease-treatment
https://www.thailandmedical.news/news/thailand-medical-study-shows-celastrus-seed-extracts-reduce-neuroinflammation
https://www.thailandmedical.news/news/phytochemicals-nobiletin-and-eriodictyol-can-help-suppress-neuroinflammation-caused-by-sars-cov-2-spike-protein
Share
Tweet
Share
